找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Oncology: Techniques, Indications, and Interpretation; Samantha L. Heller,Linda Moy Book 2017 Springer International Publishing Swi

[復制鏈接]
樓主: ACID
51#
發(fā)表于 2025-3-30 08:37:03 | 只看該作者
Business History: Travails and Trajectorieson of breast cancers. MRI is a frequently used modality for evaluating breast cancer. Tumors demonstrate varying morphologic and enhancement characteristics depending on tumor type. Knowledge of the MRI appearance of various tumors is helpful for expanding the differential diagnosis.
52#
發(fā)表于 2025-3-30 15:56:43 | 只看該作者
Law and Business: Comparative Perspectivesrelate for a lesion detected by MRI that was not initially seen at mammography or ultrasound. If a correlate is seen at ultrasound, US-guided biopsy is the preferred method as it can be less expensive, faster, easier, and more comfortable for patients than MRI-guided biopsy. Understanding the differ
53#
發(fā)表于 2025-3-30 20:00:01 | 只看該作者
Law and Business: Comparative Perspectivesexamination volumes. Alongside this there has been improved diagnostic image quality with a resulting number of breast lesions detected only on MRI requiring further clarification. International guidelines now insist that institutions performing breast MRI should provide the option of an MRI-guided
54#
發(fā)表于 2025-3-31 00:12:23 | 只看該作者
Management Education in the Network Economys. The discussion includes challenges in assessing radiologic-pathologic concordance specific to MRI, approaches for discordant biopsy results, and a review of the literature on appropriate imaging follow-up recommendations for benign concordant MRI-guided breast biopsy results. High risk lesions fr
55#
發(fā)表于 2025-3-31 04:16:03 | 只看該作者
Management Education in the Network Economysis. In this chapter, we describe the probably benign BI-RADS 3 category on MRI and report frequency and malignancy rates. The rate of malignancy in BI-RADS 3 lesions on MRI is below 2 % in the majority of studies. It is lowest in foci (0.9 %) and highest in non-mass enhancements (4 %). Malignant BI
56#
發(fā)表于 2025-3-31 05:35:13 | 只看該作者
57#
發(fā)表于 2025-3-31 09:39:03 | 只看該作者
,Effizienz versus Effektivit?t, application of MRI as a screening modality for all women, including time-consuming protocols which may occupy the MRI system for 30–60 min, and which are costly, difficult for patients and limit clinical accessibility. Recently researchers have questioned which MR sequences are truly necessary in t
58#
發(fā)表于 2025-3-31 15:02:08 | 只看該作者
Business History: Travails and Trajectorieson of breast cancers. MRI is a frequently used modality for evaluating breast cancer. Tumors demonstrate varying morphologic and enhancement characteristics depending on tumor type. Knowledge of the MRI appearance of various tumors is helpful for expanding the differential diagnosis.
59#
發(fā)表于 2025-3-31 20:38:21 | 只看該作者
Breast MRI Techniquel and adequate (≥ 1.5 T) magnetic field strength. Currently, breast MRI requires gadolinium contrast agent administration for cancer detection and a dynamic acquisition (dynamic contrast enhanced, or DCE, MRI) using a method that allows for homogenous fat suppression. In order to maximize sensitivit
60#
發(fā)表于 2025-3-31 22:12:47 | 只看該作者
Breast MRI: Standard Terminologies and Reportingncluding evaluation of extent of disease in women with a known breast malignancy. The ACR Breast Imaging Reporting and Data System (BI-RADS?) developed a common language to describe MRI findings in a clear and concise manner, which led to the breast MRI lexicon. The language used in the lexicon not
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 02:00
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
岱山县| 漾濞| 兴义市| 从化市| 务川| 漠河县| 大竹县| 穆棱市| 宣威市| 义乌市| 卢龙县| 积石山| 海南省| 合阳县| 玉溪市| 沁水县| 武功县| 通榆县| 安溪县| 浪卡子县| 临清市| 定结县| 天镇县| 天门市| 雅江县| 习水县| 元朗区| 长泰县| 彭山县| 喜德县| 巧家县| 剑河县| 宜章县| 始兴县| 衡南县| 蓝山县| 武城县| 博兴县| 姜堰市| 武宁县| 虞城县|